SHAZHOU LUO: Open Payments
NPI 1407136617 · BENTONVILLE, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,545 in 78 payments from 13 companies in 2025. Trend: 2023 $29 · 2024 $691 · 2025 $2,545
Food & beverage: $2,446Education: $99
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $481 |
| Regeneron Healthcare Solutions, Inc. | 8 | $416 |
| GENZYME CORPORATION | 9 | $309 |
| Amgen Inc. | 13 | $276 |
| Arcutis Biotherapeutics, Inc. | 13 | $272 |
| Galderma Laboratories, L.P. | 3 | $262 |
| Novartis Pharmaceuticals Corporation | 6 | $184 |
| Incyte Corporation | 4 | $92 |
| LEO Pharma Inc. | 2 | $81 |
| E.R. Squibb & Sons, L.L.C. | 2 | $58 |
Products named: DUPIXENT, SKYRIZI, OTEZLA, Zoryve, NEMLUVIO, RINVOQ, COSENTYX, OPZELURA.
Industry payments across AR — which companies pay providers there.
